Tech Company Financing Transactions
BioVentrix Funding Round
On 4/13/2023, BioVentrix announced $48.5 million in Series A funding from Andera Partners, Cormorant Asset Management and Richmond Brothers.
Transaction Overview
Company Name
Announced On
4/13/2023
Transaction Type
Venture Equity
Amount
$48,500,000
Round
Series A
Investors
Proceeds Purpose
The company intends to use the funds to support the completion of the pre-market approval (PMA) application for its Revivent TC system, manage expanded access to allow for additional procedures after the completion of enrollment in its PMA study, and initial preparations for commercial launch.
Company Information
Company Status
Private & Independent
Industry
Medical Devices & Instruments
Mailing Address
12647 Alcosta Blvd 400
San Ramon, CA 94583
USA
San Ramon, CA 94583
USA
Phone
Website
Email Address
Overview
BioVentrix is a privately held medical device company headquartered in San Ramon, CA, USA. Our mission is to improve and expand the treatment available for congestive heart failure (CHF) caused by ischemic cardiomyopathy, through the development of less invasive, catheter-based approaches.
Profile
Social Media
Company News
Facebook
YouTube
Management Team
Title
Name
Email & Social
Chief Executive Officer
James Dillon
Chief Financial Officer
William Abbott
Chief Operating Officer
Steven Chartier
Co-Founder
Lon Annest
Browse more venture capital transactions:
Prev: 4/13/2023: Omy Laboratoires venture capital transaction
Next: 4/13/2023: ThayerMahan venture capital transaction
Share this article
About Our VC Transactions Data
We do our best to record every notable VC transaction. VC investment data records on this site are derived from news reports and company announcements. The data comes to us via our partnership with VentureDeal.com, an affiliated venture.
Additional Resources for Entrepreneurs